Advertisement
Research Article| Volume 20, ISSUE 2, P303-343, June 2000

Download started.

Ok

Evaluation of Abnormal Cervical Cytology

  • J. Thomas Cox
    Correspondence
    Address reprint requests to: J. Thomas Cox, MD, MPH, University of California at Santa Barbara, Student Health Services, Santa Barbara, CA 93106
    Affiliations
    From the Student Health Services, University of California at Santa Barbara, Santa Barbara, California
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30064-7
Evaluation of Abnormal Cervical Cytology
Previous ArticleIn Situ Diagnosis of Human Papillomaviruses
Next ArticleStatistical Issues in Human Papillomavirus Testing and Screening
      This paper is only available as a PDF. To read, Please Download here.
      The introduction of widespread cervical cytologic screening in the United States and in many other developed countries is clearly one of the most dramatic preventive health measures in history. This article provides a history of cervical cancer screening and a comprehensive review of management options and techniques.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • American College of Obstetricians and Gynecologists
        Cervical Cytology: Evaluation and Management of Abnormalities. ACOG Technical Bulletin No. 183. The American College of Obstetricians and Gynecologists, Washington, DC1993
        • Anderson D.J.
        • Flannelly G.M.
        • Kitchener H.C.
        • et al.
        Mild and moderate dyskaryosis: Can women be selected for colposcopy on the basis of social criteria?.
        BMJ. 1992; 305: 84
        • Anderson M.C.
        Glandular lesions of the cervix.
        Baillieres Clin Obstet Gynecol. 1995; 9: 105
        • Ayre J.E.
        Cancer Cytology of the Uterus. Grune and Stratton, New York1951
        • Ayre J.E.
        The vaginal smear. “Precancer” cell studies using a modified technique.
        Am J Obstet Gynecol. 1949; 58: 1205
        • Babes A.
        Diagnostic du cancer du col uterine par les frottis.
        La Presse Medicale 36:451, 1928, Reprinted in English Acta Cytol. 1967; 11: 217
        • Biedermann K.
        • Bannwart F.
        • Staikov D.
        • et al.
        Pathologic Papanicolaou class IV smear without histologic correlation-What should be done?.
        Geburtshilfe Frauenheilkd. 1988; 48: 781

      8. Bogdanich: Wall Street Journal

        • Bosch F.X.
        • Manos M.M.
        • Munoz N.
        • et al.
        Prevalence of human papillomavirus in cervical cancer: A worldwide perspective.
        J Natl Cancer Inst. 1995; 87: 796
        • Bose S.
        • Karman V.
        • Kline T.S.
        Abnormal endocervical cells: Really abnormal? Really endocervical?.
        Am J Clin Pathol. 1994; 101: 708
        • Brown L.J.R.
        • Wells M.
        Cervical glandular atypia associated with squamous intraepithelial neoplasia: A premalignant lesion?.
        J Clin Pathol. 1986; 39: 22
        • Campion M.J.
        • Brown J.R.
        • McCance D.L.
        • et al.
        Psychosexual trauma of an abnormal Pap smear.
        Br J Obstet Gynecol. 1988; 95: 175
        • Chakrabarti S.
        • Guijou F.B.
        • Paraskevas M.
        Brush versus spatula for cervical smears.
        ACTA Cytol. 1994; 38: 315
        • Chamberlain J.
        Reasons that some screening programs fail to control cervical cancer.
        in: Hakama M. Miller A.B. Day N.E. Screening for Cancer of the Uterine Cervix. IARC Scientific Publications, IARC Scientific Publications No. 76. Lyon1992: 161
        • Chesebro M.J.
        • Everett W.D.
        • Lorincz A.T.
        High-risk human papillomavirus testing of women with cytological low-grade squamous intraepithelial lesions.
        J Lower Gen Tract Dis. 1997; 1: 234
        • Clavel C.
        • Masure M.
        • Putaud I.
        • et al.
        Hybrid capture II, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture I and PCR results in cervical lesions.
        J Clin Pathol. 1998; 51: 737

      17. Clinical laboratory Improvement Amendments of 1988, 42 CFR § 405

        • Coppleson M.
        • Atkinson K.H.
        • Dalrymple J.C.
        Cervical squamous and glandular neoplasia: Clinical features and review of management.
        in: Coppleson M. Gynecologic Oncology. Churchill Livingstone, Edinburgh1992: 571
        • Corkill M.
        • Knapp D.
        • Hutchinson M.L.
        Improved accuracy for cervical cytology with the ThinPrep method and the endocervical brush-spatula collection procedure.
        J Lower Gen Tract Dis. 1998; 2: 12
        • Cox J.T.
        ASSCP Practice Guideline: Management of glandular abnormalities in the cervical smear.
        J Lower Gen Tract Dis. 1997; 1: 41
        • Cox J.T.
        Clinical utility of HPV testing.
        Obstet Gynecol Clin North Am. 1996; 23: 811
        • Cox J.T.
        The Epidemiology of CIN-What Is the Role of HPV?.
        Ballieres Clin Obstet Gynecol. 1995; 9: 1
        • Cox J.T.
        Evaluating the role of HPV testing for women with equivocal Papanicolaou test findings, [editorial].
        JAMA. 1999; 281: 1645

      24. Cox JT, Lonky N, Tosh R et al: ASSCP Practice Guideline: Management of low-grade squamous intraepithelial lesion (LSIL). J Lower Gen Tract Dis, in press

        • Cox J.T.
        • Lorincz A.T.
        • Schiffman M.H.
        • et al.
        HPV testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of ASCUS.
        Am J Obstet Gynecol. 1995; 172: 946
        • Cox J.T.
        • Schiffman M.H.
        • Wentzleberg A.
        • et al.
        An evaluation of HPV testing as part of referral to colposcopy clinic.
        Obstet Gynecol. 1992; 80: 389
        • Creaseman W.T.
        • Weed J.C.
        • Curry S.L.
        • et al.
        Efficacy of cryosurgical treatment of severe cervical intraepithelial neoplasia.
        Obstet Gynecol. 1972; 41: 501
        • Cuzick J.
        Cervical screening.
        Br J Hosp Med. 1988; 39: 265
        • Cuzick J.
        • Terry G.
        • Ho L.
        • et al.
        Type-specific HPV DNA as a predictor of high grade cervical intraepithelial neoplasia.
        Br J Cancer. 1994; 69: 167
        • Davey D.D.
        • Naryshkin S.
        • Nielsen M.L.
        • et al.
        Atypical squamous cell of undetermined significance: Interlaboratory comparison and quality assurance monitors.
        Diagn Cytopathol. 1994; 11: 390
        • Demirkiran F.
        • Arvas M.
        • Erkun E.
        • et al.
        The prognostic significance of cervico-vaginal cytology in endometrial cancer.
        Eur J Gynecol Oncol. 1995; 16: 404
        • Devesa S.S.
        Descriptive epidemiology of cancer of the uterine cervix.
        Obstet Gynecol. 1984; 63: 605
        • Diaz-Rosario L.A.
        • Kabawat S.E.
        Performance of a fluid based, thin-layer Papanicolaou smear method in the clinical setting of an independent laboratory and an outpatient screening population in New England.
        Arch Pathol Lab Med. 1999; 123: 817
        • Dodd L.
        • Sniege M.
        • Villarreal Y.
        • et al.
        Quality assurance study of simultaneously sampled non-correlating cervical cytology and biopsies.
        Diagn Cytopathol. 1993; 9: 138
        • Dupree W.B.
        • Suprun H.Z.
        • Beckwith D.G.
        • et al.
        The promise and risk of a new technology: The Lehigh Valley Hospital’s experience with liquid-based cervical cytology.
        Cancer. 1998; 84: 202
        • Duska L.R.
        • Flynn C.F.
        • Chen A.
        • et al.
        Clinical evaluation of atypical glandular cells of undetermined significance on cervical cytology.
        Obstet Gynecol. 1998; 91: 278
        • Eddy G.L.
        • Strumpf K.B.
        • Wojtowycz M.A.
        • et al.
        Biopsy findings in 531 patients with atypical glandular cells of undetermined significance (AGCUS) as defined by the Bethesda System (TBS).
        Am J Obstet Gynecol. 1997; 177: 1188
        • Eddy G.L.
        • Wojtowycz M.A.
        • Piraino P.S.
        • et al.
        Papanicolaou smears by the Bethesda System in endometrial malignancy: Utility and prognostic importance.
        Obstet Gynecol. 1997; 90: 999
        • Elwood J.M.
        • Cotton R.E.
        • Johnson J.
        • et al.
        Are patients with abnormal smears adequately managed?.
        BMJ. 1984; 289: 891

      40. Evaluation of cervical cytology. Evidence report/technology assessment No. 5. 1999. Rockville, MD, AHCPR Publication 99-E010

        • Fahey M.T.
        • Irwig L.
        • Macaskill P.
        Meta-analysis of Pap test accuracy.
        Am J Epidemiol. 1995; 141: 680
        • Ferenczy A.
        Viral testing for genital human papillomavirus infections: Recent progress and clinical potentials.
        Int J Gynecol Cancer. 1995; 5: 321
        • Ferris D.G.
        • Cox J.T.
        • Burke L.
        • et al.
        Colposcopy quality control: Establishing colposcopy criterion standards for the NCI ALTS Trial.
        J Lower Gen Tract Dis. 1998; 2: 1195
        • Ferris D.G.
        • Krumholz B.A.
        • Jester D.M.
        • et al.
        Atypical glandular cells of undetermined significance and adenocarcinoma in situ: Summoning colposcopic expertise?.
        J Fam Pract. 1996; 43: 181
        • Ferris D.G.
        • Wright T.C.
        • Litaker M.S.
        • et al.
        Triage of women with ASCUS and LSIL Pap smear reports: Management by repeat Pap smear, HPV DNA testing or colposcopy?.
        J Fam Pract. 1998; 46: 125
        • Giles J.A.
        • Hudson E.
        • Crow J.
        • et al.
        Colposcopic assessment of the accuracy of cervical cytologic screening.
        BMJ. 1988; 296: 1099
        • Goff B.A.
        • Atanosoff P.
        • Brown E.
        • et al.
        Endocervical glandular atypia in Pap smears.
        Obstet Gynecol. 1992; 79: 101
        • Gordon P.
        • Hatch K.
        Survey of colposcopy practices by Obstetricians/Gynecologists.
        J Reprod Med. 1992; 37: 861
        • Hall S.
        • Wu T.C.
        • Soudi N.
        • et al.
        Low-grade squamous intraepithelial lesions: Cytologic predictors of biopsy confirmation.
        Diagn Cytopathol. 1994; 10: 3
        • Hellberg D.
        • Nilsson S.
        • Valentin J.
        Positive cervical smear with subsequent normal colposcopy and histology-frequency of CIN in a long-term follow-up.
        Gynecol Oncol. 1994; 53: 148
        • Horn P.L.
        • Lowell D.M.
        • Livosi V.A.
        • et al.
        Reproducibility of the cytologic diagnosis of HPV infection.
        Acta Cytol. 1985; 29: 692
        • Ishmail S.M.
        • Colclough A.B.
        • Dennen J.S.
        • et al.
        Reporting cervical intraepithelial neoplasia (CIN): Intra-and interpathologist variation and factors associated with disagreement.
        Histopathology. 1990; 16: 371
        • Jaworski R.C.
        Endocervical glandular dysplasia, adenocarcinoma in situ and early invasive (microinvasive) adenocarcinoma of the uterine cervix.
        Semin Diagn Pathol. 1990; 7: 190
        • Jenkins D.
        • Sherlaw-Johnson C.
        • Gailivan S.
        Assessing the role of HPV testing in cervical cancer screening.
        Papillomavirus Report. 1998; 4: 89
        • Jones M.H.
        • Singer A.
        • Jenkins D.
        The mildly abnormal cervical smear: Patient awareness and choice of management.
        J R Soc Med. 1996; 89: 257
        • Jovanovic A.S.
        • McLachlin C.M.
        • Shen L.
        • et al.
        Post-menopausal squamous atypia: A spectrum including “pseudo-koilocytosis.”.
        Mod Pathol. 1995; 8: 408
        • Kainz C.
        • Tempfer C.
        • Gitsch G.
        • et al.
        Influence of age and human papillomavirus infection on reliability of cervical cytology.
        Arch Gynecol Obstet. 1995; 256: 23
        • Kato I.
        • Santamaria M.
        • De Ruiz P.A.
        • et al.
        Interobserver variation in cytological and histological diagnoses of cervical neoplasia and its epidemiologic implication.
        J Clin Epidemiol. 1995; 48: 1167
        • Kaufman R.H.
        • Adam E.
        • Icenogle J.
        • et al.
        Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia.
        Am J Obstet Gynecol. 1997; 176: 87
        • Kennedy A.W.
        • Salmieri S.S.
        • Wirth S.L.
        • et al.
        Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening.
        Gynecol Oncol. 1996; 63: 14
        • Kinney W.K.
        • Manos M.M.
        • Hurley L.B.
        • et al.
        Where’s the high-grade cervical neoplasia? The importance of the minimally abnormal Papanicolaou diagnosis.
        Obstet Gynecol. 1998; 91: 973
        • Koike N.
        Efficacy of the cytobrush method in aged patients.
        Diagn Cytopathol. 1994; 38: 310
        • Koss L.G.
        • Durfee G.R.
        Unusual patterns of squamous epithelium of the uterine cervix: Cytologic and pathologic study of koilocytotic atypia.
        Ann N Y Acad Sei. 1956; 63: 1245
        • Koutsy LA for the ALTS Group
        Human papillomavirus testing for a triage of women with cytologic evidence of low-grade squamous intraepithelial lesions; Baseline data from a randomized trial.
        J Natl Cancer Inst. 2000; 92: 397-402
        • Krone M.R.
        • Kiviat N.B.
        • Koutsky L.A.
        The epidemiology of cervical neoplasms.
        in: Luesley D. Jordan J. Richart R.M. Intraepithelial Neoplasia of the Lower Genital Tract. Churchill-Livingston, Edinburgh1995: 49
        • Kurman R.J.
        • Henson D.
        • Herbst A.
        • et al.
        Interim guidelines for management of abnormal cervical cytology.
        JAMA. 1994; 271: 1866
        • Kurman R.J.
        • Solomon D.
        The Bethesda System for reporting cervical/ vaginal cytologic diagnoses. Definitions, criteria, and explanatory notes for terminology and specimen adequacy. Springer-Verlag, New York1993
        • Landis S.H.
        • Murray T.
        • Bolden S.
        • et al.
        Cancer statistics 1998.
        CA Cancer J Clin. 1998; 48: 6
        • Larson A.A.
        • Liao S-Y
        • Stanbridge E.J.
        • et al.
        Genetic alterations accumulate during cervical tumorigenesis and indicate a common origin for multifocal lesions.
        Cancer Res. 1997; 57: 4171
        • Larson D.M.
        • Johnson K.K.
        • Reyes C.N.
        • et al.
        Prognostic significance of malignant cervical cytology in patients with endometrial cancer.
        Obstet Gynecol. 1994; 84: 399
        • Lee K.R.
        • Manna E.A.
        • St. John T.
        Atypical endocervical glandular cells: Accuracy of cytologic diagnosis.
        Diagn Cytopathol. 1995; 13: 202
        • Lee K.R.
        • Minter L.J.
        • Crum C.P.
        Koilocytotic atypia in Papanicolaou smears: Reproducibility and biopsy correlation.
        Cancer Cytopathol. 1997; 81: 10
        • Lindheim S.R.
        • Smith-Nguyen G.
        Aggressive evaluation for atypical squamous cells in Papanicolaou smears.
        J Reprod Med. 1990; 35: 971
        • Lonky N.M.
        • Navarre G.L.
        • Saunder S.
        • et al.
        Low-grade Papanicolaou smears and the Bethesda Systems: A prospective cytopathologic analysis.
        Obstet Gynecol. 1995; 85: 716
        • Manos M.M.
        • Kinney W.K.
        • Hurley L.B.
        • et al.
        Identifying women with cervical neoplasia: Using human papillomavirus testing for equivocal Papanicolaou results.
        JAMA. 1999; 281: 1605
        • Mayeaux E.J.
        • Harper M.B.
        • Abreo F.
        • et al.
        A comparison of the reliability of repeat cervical smears and colposcopy in patients with abnormal cervical cytology.
        J Fam Pract. 1995; 40: 57
        • Meijer C.J.L.M.
        • van den Brule A.J.C.
        • Snijders P.J.F.
        • et al.
        Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: Possible implications for cervical cancer screening.
        in: Munoz N. Bosch F.X. Shah K.V. The Epidemiology of Human Papillomavirus and Cervical Cancer. Oxford University Press, New York1992: 271
        • Meisels A.
        • Fortein R.
        Condylomatous lesions of the cervix and vagina. I. Cytologic patterns.
        Acta Cytol. 1976; 20: 505
        • Meisels A.
        • Morin C.
        Cytopathology of the Uterine Cervix. ASCP Press, Chicago1990: 179
        • Montz F.J.
        • Monk B.J.
        • Fowler J.M.
        • et al.
        Natural history of the minimally atypical Papanicolaou smear.
        Obstet Gynecol. 1992; 80: 385
        • Nasiell K.
        • Nasiell M.
        • Vaklavinkova V.
        Behavior of moderate cervical dysplasia during long-term follow-up.
        Obstet Gynecol. 1983; 61: 609
        • Nasu I.
        • Meurer W.
        • Fu Y.S.
        Endocervical glandular atypia and adenocarcinoma: A correlation of cytology and histology.
        Int J Gynecol Pathol. 1993; 12: 208
        • National Cancer Institute Workshop
        The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnosis.
        JAMA. 1989; 262: 931
        • Nuovo G.J.
        • Moritz J.
        • Walsh L.L.
        • et al.
        Predictive value of human papillomavirus detection by filter hybridization and PCR in women with negative results on colposcopic examination.
        Am J Clin Pathol. 1992; 98: 489
        • Ostor A.G.
        Natural history of CIN: A critical review.
        Int J Gynecol Pathol. 1993; 12: 186

      86. Papanicolaou GN: 1928

        • Papanicolaou G.N.
        • Traut H.F.
        Diagnosis of Uterine Cancer by the Vaginal Smear. Commonwealth Fund, New York1943
        • Papillo J.L.
        • Zarka M.A.
        • St. John T.L.
        Evaluation of the ThinPrep Pap Test in clinical practice: A seven-month, 16,314-case experience in northern Vermont.
        Acta Cytol. 1998; 42: 203
        • Parkin D.M.
        • Pisani P.
        • Ferlay J.
        Estimates of the worldwide incidence of 18 major cancers in 1985.
        Int J Cancer. 1993; 54: 594
        • Parrazini F.
        • Sideri M.
        • Restelli S.
        • et al.
        Determinants of high-grade dysplasia among women with mild dyskaryosis on cervical smear.
        Obstet Gynecol. 1995; 86: 754
        • Patsner B.
        Diagnosis and contemporary management of cervical intraepithelial neoplasia.
        Advances in Obstetrics and Gynecology. 1994; 1: 261
        • Poljiak M.
        • Brencic A.
        • Seme K.
        • et al.
        Comparative evaluation of first-and second generation Digene Hybrid capture assays for detection of human papillomavirus associated with high or intermediate risk for cervical cancer.
        J Clin Microbiol. 1999; 37: 796
        • Prendiville W.
        • Cullimore J.
        • Norman S.
        Large loop excision of the transformation zone (LLETZ): A new method of management for women with intraepithelial neoplasia.
        Br J Obstet Gynecol. 1989; 96: 1054
        • Quantin C.
        • Dusserre L.
        • Montaud A.M.
        • et al.
        A model for quality assessment in cervical cytology used as a screening test.
        Qual Assur Health Care. 1992; 4: 105
        • Raab S.S.
        • Snider T.E.
        • Potts S.A.
        • et al.
        Atypical glandular cells of undetermined significance: Diagnostic accuracy and interobserver variability using select cytologic criteria.
        Am J Clin Pathol. 1997; 107: 299
        • Rader J.S.
        • Rosenzweig B.A.
        • Spirtas R.
        • et al.
        Atypical squamous cells: A case-series study of the association between Papanicolaou smear results and human papillomavirus DNA genotype.
        J Reprod Med. 1991; 36: 291
        • Raffle A.E.
        • Alden B.
        • MacKenzie E.F.D.
        Detection rates for abnormal cervical smears: What are we screening for?.
        Lancet. 1995; 345: 1469
        • Ramirez E.J.
        • Hernandez E.
        • Miyazawa K.
        Cervical conization findings in women with dysplastic cervical cytology and normal colposcopy.
        J Reprod Med. 1990; 35: 359
        • Reid R.
        • Cox J.T.
        Human papillomavirus testing: Major advance or scientific hoax?.
        in: Luesley D. Jordan J. Richart R.M. Intraepithelial Neoplasia of the Lower Genital Tract. Churchill-Livingston, London1995: 197
        • Richart R.M.
        A clinical staining test for the in vivo delineation of dysplasia and carcinoma in situ.
        Am J Obstet Gynecol. 1963; 86: 703
        • Richart R.M.
        • Nuovo G.J.
        Human papillomavirus DNA in situ hybridization may be used for the quality control of genital tract biopsies.
        Obstet Gynecol. 1990; 75: 223
        • Richart R.M.
        • Sciarra J.J.
        Treatment of cervical dysplasia by outpatient electrocauterization.
        Am J Obstet Gynecol. 1968; 101: 200
        • Richart R.M.
        • Wright T.C.
        The pathology of cervical neoplasia.
        in: Luesley D. Jordan J. Richart R.M. Intraepithelial Neoplasia of the Lower Genital Tract. Churchill-Livingstone, London1995: 19
        • Robertson A.J.
        • Anderson J.M.
        • Swanson Beck J.
        • et al.
        Observer variability in histopatho-logical reporting of cervical biopsy specimens.
        J Clin Pathol. 1989; 42: 231
        • Samaratunga H.
        • Cox N.
        • Wright R.G.
        Human papillomavirus in glandular lesions of the uterine cervix.
        J Clin Pathol. 1993; 46: 718
        • Saminathan T.
        • Lahoti C.
        • Karman V.
        • et al.
        Post-menopausal squamous-cell atypias: A diagnostic challenge.
        Diagn Cytopathol. 1994; 11: 226
        • Schiffman M.H.
        Commentary. Recent progress in defining the epidemiology of HPV infection and cervical neoplasia.
        J Natl Cancer Inst. 1992; 84: 394
        • Schiffman M.H.
        • Manos M.M.
        • Sherman M.E.
        • et al.
        Response: Human papillomavirus and cervical intraepithelial neoplasia.
        J Natl Cancer Inst. 1993; 85: 1868
        • Schiffman M.
        • Solomon D.
        • Liaw K.L.
        • et al.
        Why, how and when the cytologic diagnosis of ASCUS should be eliminated.
        J Lower Tract Dis. 1998; 2: 165
        • Sherman M.E.
        • Kelly D.
        High-grade squamous intraepithelial lesions and invasive carcinoma following the report of three negative Papanicolaou smears: Screening failures or rapid progression?.
        Mod Pathol. 1992; 5: 337
        • Sherman M.
        • Schiffman M.H.
        • Cox J.T.
        The Bethesda System: Biological and clinical correlates.
        Pathol Case Rev. 1997; 2: 3
        • Sherman M.E.
        • Schiffman M.H.
        • Lorincz A.T.
        • et al.
        Towards objective quality assurance in cervical cytopathology: Correlation of cytopathologic diagnosis with detection of high risk HPV types.
        Am J Clin Pathol. 1994; 102: 182
        • Shoyer K.R.
        • Lovelace G.S.
        • Abarca M.L.
        • et al.
        Detection of human papillomavirus DNA by in situ hybridization and polymerase chain reaction in human papillomavirus equivocal and dysplastic cervical biopsies.
        Hum Pathol. 1993; 24: 1012
        • Sidaway M.K.
        • Tabara S.O.
        Reactive change and ASCUS in Pap smears: A cytohistologic correlation.
        Diagn Cytopathol. 1993; 9: 423
        • Sigurdsson K.
        What is the effect of cervical screening on the incidence of adenocarcinoma?.
        Int J Cancer. 1993; 54: 563
        • Skegg D.C.G.
        Commentary: Cervical screening blues.
        Lancet. 1995; 345: 1451
        • Slawson D.C.
        • Bennett J.H.
        • Herman J.M.
        Follow-up Papanicolaou smear for cervical atypia. Are we missing significant disease?.
        J Fam Pract. 1993; 36: 289
        • Slawson D.C.
        • Bennett J.H.
        • Simon L.J.
        • et al.
        Should all women with cervical atypia be referred for colposcopy? A HARTNET study.
        J Fam Pract. 1994; 38: 387
        • Soutter W.P.
        A critical appraisal of screening and diagnostic techniques.
        in: Luesley D. Jordan J. Richart R.M. Intraepithelial Neoplasia of the Lower Genital Tract. Churchill-Livingstone, London1995: 293
        • Takezawa K.
        • Bennett B.B.
        • Wilkinson E.J.
        • et al.
        Squamous intraepithelial lesions of the cervix in a high risk population.
        J Lower Gen Tract Dis. 1998; 2: 136-140
      121. The 1991 Bethesda System for reporting cervical/vaginal cytological diagnoses.
        Diagn Cytopathol. 1993; 9: 235
        • Ueki M.
        Cervical Adenocarcinoma: A Colposcopic Atlas. Ishiyaku EuroAmerican, St. Louis1983: 12
        • Vizcaino A.P.
        • Moreno V.
        • Bosch F.X.
        • et al.
        International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas.
        Int J Cancer. 1998; 75: 536
        • Vooijs G.P.
        Benign proliferative reactions, intraepithelial neoplasia and invasive cancer of the uterine cervix.
        in: Bibbo M. Comprehensive Cytopathology. ed 1. WB Saunders, Philadelphia1991: 224
        • Wheelock J.B.
        • Kaminsky P.F.
        Value of repeat cytology at the time of colposcopy for the evaluation of cervical intraepithelial neoplasia on Papanicolaou smears.
        J Reprod Med. 1989; 43: 815
        • Widra E.A.
        • Dookhan D.
        • Jordan A.
        • et al.
        Evaluation of the atypical cytologic smear. Validity of the 1991 Bethesda System.
        J Reprod Med. 1994; 39: 682
        • Wright T.C.
        • Denny L.
        • Kuhn L.
        • et al.
        NPV DNA testing of self collected vaginal samples compared with cytologic screening to detect cervical cancer.
        JAMA. 2000; 283: 81-86
        • Wright T.C.
        • Lorincz A.T.
        • Ferris D.G.
        • et al.
        Reflex human papillomavirus deoxyribonu-cleic acid testing in women with abnormal Pap smears.
        Am J Obstet Gynecol. 1998; 178: 962
        • Wright T.C.
        • Sun X.W.
        • Koulos J.
        Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities.
        Obstet Gynecol. 1995; 85: 202

      130. Wright VC, Davies E, Riopelle MA: Laser surgery for cervical intraepithelial neoplasia: Principles and results. Am J Obstet Gynecol 145, 1983

        • Xi L.F.
        • Koutsky L.A.
        • Galloway D.A.
        • et al.
        Genomic variation of human papillomavirus type 16 and risk for high-grade cervical intraepithelial neoplasia.
        J Natl Cancer Inst. 1997; 89: 796
        • Zehbe I.
        • Wilander E.
        • Delius H.
        • et al.
        Human papillomavirus 16 E6 variants are more prevalent than the prototype.
        Cancer Res. 1998; 58: 829
        • Zweizig S.
        • Noller K.
        • Reale F.
        • et al.
        Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology.
        Gynecol Oncol. 1997; 65: 314

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30064-7

      Copyright

      © 2000 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX